Robert Weisman

Weisman covers the healthcare and life sciences industries for the Business section. He was a business reporter and editor for the Hartford Courant and the Seattle Times before joining the Globe in 2000.

Latest stories

Five things you should know about Nancy Simonian

By , Globe Staff

Dr. Simonian is chief executive at Syros Pharmaceuticals Inc. in Watertown.

Cystic fibrosis drug could bring millions to executives

By , Globe Staff

If the drug is approved, Vertex executives could reap $53 million in bonuses while patients pay hundreds of thousands per year.

Blueprint shares up after raising $147 million in IPO

By , Globe Staff

Shares of Blueprint Medicines, a cancer drug startup based in Cambridge, opened on the Nasdaq Stock Market Thursday.

Biogen chief draws $18.6 million pay package

By , Globe Staff

The pay package for George Scangos rose 24 percent from the $15 million he received in 2013.